Lymphocytes in pleural disease

Current Opinion in Pulmonary Medicine

Volumn 11, Issue 4, 2005, Pages 334-339

  Dalbeth, Nicola ^a   Lee, Y C Gary ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Lymphocyte; Malignancy; Pleural effusion; Tuberculosis

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; HUMAN; LYMPHOCYTE; NATURAL KILLER CELL; PLEURA DISEASE; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 23044502226     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000166490.92659.17     Document Type: Review

References (47)

1. Heffner JE. Pleural effusion: pleural fluid analysis, thoracentesis, biopsy, and chest tube. In Encyclopedia of Respiratory Diseases. Edited by Laurent GJ, Shapiro S. Oxford, UK: Elsevier; In press.
2. Light RW. Pleural diseases, 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2001.
3. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8:275-283.
4. Francois Bach J. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3:189-198.
5. Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195:327-333.
6. San Jose ME, Valdes L, Saavedra MJ, et al. Lymphocyte populations in tuberculous pleural effusions. Ann Clin Biochem 1999; 36:492-500.
7. Marelli-Berg FM, James MJ, Dangerfield J, et al. Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo. Blood 2004; 103:3111-3116. This paper demonstrates that antigen presentation by the endothelium induces selective T-cell migration into inflammatory sites.
8. Sampaio AL, Rae GA, Henriques MG. Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation. J Leukoc Biol 2004; 76:210-216. Using a model of LPS-induced pleuritis, these authors reported that antagonism of the endothelin ETA receptor suppressed the accumulation of a number of cell types, including CD4 and CD8 T cells.
9. Teng R, Johkura K, Ogiwara N, et al. Morphological analysis of leucocyte transmigration in the pleural cavity. J Anat 2003; 203:391-404.
10. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002; 16:67-76.
11. Pace E, Gjomarkaj M, Melis M, et al. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Am J Respir Crit Care Med 1999; 159:1592-1599.
12. Penido C, Vieira-de-Abreu A, Bozza MT, et al. Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guerin. J Immunol 2003; 171:6788-6794.
13. Oshikawa K, Yanagisawa K, Ohno S, et al. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 2002; 165:1005-1009.
14. Lee YC, Lane KB. Cytokines in pleural diseases. In Textbook of Pleural Diseases. Edited by Light RW, Lee YC. London, UK: Arnold Press; 2003:63-89.
15. Porta C, Danova M, Orengo AM, et al. Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro. J Cell Physiol 2000; 185:126-134.
16. Nasreen N, Mohammed KA, Galffy G, et al. MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 278:L591-L598.
17. Chen YM, Tsai CM, Whang-Peng J, et al. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions. J Interferon Cytokine Res 2001; 21:249-256.
18. Chen YM, Ting CC, Peng JW, et al. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2. J Interferon Cytokine Res 2000; 20:31-39.
19. Kalomenidis I, Mohamed KH, Lane KB, et al. Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. Chest 2003; 124:159-166.
20. Heymann D, L'Her E, NGuyen JM, et al. Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF). Cytokine 1996; 8:410-416.
21. Mohamed KH, Abdelhamid AI, Lee YC, et al. Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest 2002; 122:576-580.
22. Sikora JJ, Dworacki GT, Kaczmarek MT, et al. Immunosuppressive mechanisms in the microenvironment of malignant pleural effusions. Cancer Detect Prev 2004; 28:325-330.
23. Olobo JO, Geletu M, Demissie A, et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001; 53:85-91.
24. Melis M, Pace E, Siena L, et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med 2003; 167:1131-1138.
25. Sedberry Allen S, McMurray DN. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect Immunol 2003; 71:4271-4277.
26. Green LK, Griffin J. Increased natural killer cells in fluids. A new, sensitive means of detecting carcinoma. Acta Cytol 1996; 40:1240-1245.
27. Okubo Y, Nakata M, Kuroiwa Y, et al. NK cells in carcinomatous and tuberculous pleurisy. Phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions. Chest 1987; 92:500-504.
28. Laurini JA, Garcia A, Elsner B, et al. Relation between natural killer cells and neoplastic cells in serous fluids. Diagn Cytopathol 2000; 22:347-350.
29. Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136:4480-4486.
30. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001; 97:3146-3151.
31. Jacobs R, Hintzen G, Kemper A, et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001; 31:3121-3127.
32. Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166:6477-6482.
33. Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101:3052-3057.
34. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004; 172:1455-1462.
35. bright subset of NK cells is greatly expanded at sites of inflammation, including in malignant pleural effusions. These cells have reduced cytotoxic capacity, and their presence may contribute to the impaired immune regulation of tumours in malignant pleural disease.
36. Chen YM, Yang WK, Ting CC, et al. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. Chest 1997; 112:960-966.
37. Shen Y, Zhou D, Qiu L, et al. Adaptive immune response of Vgamma2V-delta2+ T cells during mycobacterial infections. Science 2002; 295:2255-2258.
38. Henderson RB, Hobbs JA, Mathies M, et al. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 2003; 102:328-335.
39. Villena V, Lopez-Encuentra A, Pozo F, et al. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med 2003; 115:365-370.
40. Wilkinson KA, Wilkinson RJ, Pathan A, et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005; 40:184-187. This small study reported that ESAT-6-specific, IFN-γ-producing T cells are highly concentrated in tuberculous pleural fluid, and that these cells have phenotypic characteristics of Th1 effector memory CD4 cells. This test shows promise for rapid diagnosis of tuberculous pleuritis.
41. Jackaman C, Bundell CS, Kinnear BF, et al. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. J Immunol 2003; 171:5051-5063.
42. Ebstein F, Sapede C, Royer PJ, et al. Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells. Am J Respir Crit Care Med 2004; 169:1322-1330. This paper reported the development of an in-vitro system for the development of a therapeutic vaccine against malignant mesothelioma. Dendritic cells pulsed with apoptotic mesothelioma cells were capable of inducing tumour-specific CTL responses.
43. Friedlander PL, Delaune CL, Abadie JM, et al. Efficacy of CD40 ligand gene therapy in malignant mesothelioma. Am J Respir Cell Mol Biol 2003; 29:321-330.
44. Nowak AK, Robinson BW, Lake RA. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res 2003; 63:4490-4496.
45. DeLong P, Tanaka T, Kruklitis R, et al. Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res 2003; 63:7845-7852.
46. Kruklitis RJ, Singhal S, Delong P, et al. Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. J Thorac Cardiovasc Surg 2004; 127:123-130. This study demonstrated that treatment with adenovirus encoding interferon-β before surgical debulking significantly reduces tumour recurrence and long-term tumour-free survival in mice with large tumours.
47. Ren S, Terman DS, Bohach G, et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 2004; 126:1529-1539. This report of intrapleural instillation of Staphylococcus superantigen in 14 patients with malignant pleural effusions resulting from nonsmall cell lung cancer and poor performance status showed promising clinical results.